Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-010783
Filing Date
2013-08-14
Accepted
2013-08-14 15:07:15
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro20130630_10q.htm 10-Q 827428
2 EXHIBIT 31.1 ex31-1.htm EX-31 16394
3 EXHIBIT 31.2 ex31-2.htm EX-31 16663
4 EXHIBIT 32.1 ex32-1.htm EX-32 7463
5 EXHIBIT 32.2 ex32-2.htm EX-32 6970
  Complete submission text file 0001437749-13-010783.txt   7768465

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ahro-20130630.xml EX-101.INS 728581
7 EXHIBIT 101.SCH ahro-20130630.xsd EX-101.SCH 41433
8 EXHIBIT 101.CAL ahro-20130630_cal.xml EX-101.CAL 27653
9 EXHIBIT 101.DEF ahro-20130630_def.xml EX-101.DEF 219505
10 EXHIBIT 101.LAB ahro-20130630_lab.xml EX-101.LAB 351347
11 EXHIBIT 101.PRE ahro-20130630_pre.xml EX-101.PRE 224890
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 131037352
SIC: 2834 Pharmaceutical Preparations